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OVERVIEW OF THE CALCULATION 
In  any  reaction  mixture in which the  prothrombinase  can 
assemble, factor Xa can distribute between four enzymatic 
species, as  illustrated  in Fig. 1. Of these,  the full prothrom- 
binase has by far the greatest enzymatic activity. When a 
significant fraction of available factor  Xa (>I%) is  present  in 
this complex, the  activities of the  remaining species can be 
ignored. Most of the equilibrium constants for formation of 
the species illustrated  in Fig. 1 have been measured under a 
variety of conditions.  Our  approach  to  the problem of defining 
the  properties of the fully assembled  prothrombinase  has been 
to calculate the  fraction of factor  Xa  present in this species 
and  then  to  correct observed activities by this  fraction (see 
Table I1 under  “Results” of accompanying  paper  (Pei et al. 
(1993)). Alternatively, it was possible to calculate the  initial 
rate of thrombin  generation a t  any phospholipid concentra- 
tion (e.g. to  simulate  the  data  in Fig. 2 of accompanying paper 
(Pei et al., 1993)) from the  calculated  concentration of fully 
assembled prothrombinase (Xa.  Va. PL)’ and  the  kinetic  con- 
stants for this enzyme  species. The calculations of equilibrium 
distributions of enzyme  species are described in  detail below. 
ASSUMPTIONS OF THE CALCULATIONS 
Simple Binding Equilibria Describe the Assembly of the 
Prothrombinase-We assume  that four  enzymatic forms co- 
exist in solution: factor Xa in bulk aqueous solution, x a ;  
factor  Xa bound to  the phospholipid membrane  surface,  Xa. 
PL;  factor  Xa  bound  to  factor Va in the bulk  aqueous solution, 
Xa.  Va(aq);  and  factor  Xa bound to  factor Va on  the  phos- 
pholipid membrane surface, Xa.Va. PL (Fig. 1). An added 
complication not explicitly portrayed in this scheme is the 
fact  that  both  prothrombin  and  its proteolysis products,  frag- 
ment 1.2 and  fragment 1, also bind  to  the  membrane surface. 
Our assumption is that  there  exists  an equilibrium distribu- 
tion of the various protein species  between the  solution  and 
surface  phases of the  reaction  mixture.  Binding  parameters 
utilized  have  been obtained from our  laboratory  and  others. 
Equilibrium constants  and  stoichiometries for the  binding of 
human  factor  Xa  and  prothrombin  to acidic  lipid membranes 
(Cutsforth et al., 1989) were used rather  than  those previously 
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FIG. 1. Four enzyme  species are  in equilibrium in solutions 
containing the components of the prothrombinase complex. 
Only the fully assembled prothrombinase, (Xa. Va. PL), makes a 
significant  contribution  to  prothrombin  activation. 
reported for the bovine proteins  (Nelsestuen  and Broderius, 
1977). For equilibria  involving factor Va, we have been forced 
to use values obtained for the bovine protein (see below). 
Using values from a variety of sources and from different 
mamalian species suffers from obvious disadvantages. How- 
ever, the  fact  that  parameters for prothrombin  and  factor  Xa 
were quite consistent between the two species and between 
two laboratories provided some  justification for what seemed 
a  reasonable first  approach  to a  complex  problem. When  data 
were not directly available for binding to membranes of a 
particular phospholipid composition, dissociation constants 
were estimated by interpolation or extrapolation from plots 
of log Kd versus log phospholipid  composition. 
For  the dissociation constant of factor  Xa bound to  factor 
Va in  aqueous solution,  Lindhout et al. (1982) have reported 
a  value of 3 X lo-’ M. This  parameter value was determined 
by kinetic  experiments.  Krishnaswany (1990) has quoted an 
unpublished  direct hydrodynamic result of E.  Pryzdial and  K. 
G. Mann  as giving a value of to lo-%. For  historical 
reasons,  the value of Lindhout et al. (1982) was used in most 
of our simulations.  For  comparison,  simulations were also run 
with  a value of M. Because of the low concentration of 
free factor Va in the presence of even minimal  concentrations 
of phospholipid, the  uncertainty  in  this value was found  to 
have very little  quantitative influence on our results. 
Reported values for the Kd of factor Va binding to PS 
membranes have varied over several orders of magnitude 
(Bloom et al., 1979; Higgins and Mann, 1983; Pusey and 
Nelsestuen, 1983; van de Waart et al., 1984; Krishnaswamy 
and  Mann, 1988). This variability  probably  reflects the  diffi- 
cult  experimental  task of measuring  the dissociation constant 
of a  very tight  binding  interaction.  This a key parameter  in 
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FIG. 2. Sensitivity of simulated phospholipid titration of 
prothrombinase kinetics to key binding constants. y-axis units 
are nmole thrombin liter” min”. Each family of curves was obtained 
by incrementing a  single dissociation constant (as indicated in each 
frame) while holding all others constant. Except for the incremented 
variable, all other parameter values were unchanged and were those 
used for 25:75 PS:PC. Concentrations of prothrombinase components 
were: prothrombin, 0.12 PM; factor Xa, 0.1 nM; factor Va, 1.2 nM. 
our calculations. We  have  chosen  to use the values for PS 
membranes  reported by Krishnaswamy  and  Mann (1988) and 
extended by Cutsworth et al.,’ since they were obtained by 
both kinetic and equilibrium measurements using methods 
that seemed least likely to  result  in  artifacts.  It was gratifying 
that  this choice caused the simulation to fit observed data 
significantly better  than  other  estimates of this  binding  con- 
stant. 
Three-body  Interactions  Involved in  Prothrombinase  Assem- 
bly Can Be Described Empirically in Terms of Factor X a  
Binding  to Factor Va  Bound  to  a  Membrane-Our algorithm 
treats  factor  Va.PL  as if it  were the  binding  site for factor 
Xa,  similar  to  earlier  treatments  (Nesheim et al., 1979, 1981; 
Tracy et  al., 1981).  This  assumption may not  be  mechanisti- 
cally correct, as recent work of Krishnaswamy and Mann 
(1988)  suggests that  both  factor  Xa  and  factor Va bind  inde- 
pendently to the membrane surface before interacting with 
each other to form the prothrombinase complex. However, 
the effect of the  interaction between factor  Xa  and  factor Va 
on  the  surface  can  be  incorporated rigorously into a thermo- 
dynamic  constant describing the  binding of factor  Xa  to  Va. 
PL. This empirical binding constant is thermodynamically 
equivalent  to (Kd3 X Kd2)/[PL]) in the  mechanistic  treatment 
outlined in Equations 2-4 of Krishnaswamy (1990). In the 
treatment of Krishnaswamy, Kd3 reflects the interaction of 
membrane  bound  factor  Xa  and  membrane  bound  factor Va, 
while Kd2 reflects the interaction between factor Xa and a 
procoagulant membrane.  Thus,  our  empirical  prothrombinase 
assembly constant reflects the  interaction of factor Xa  with 
both  the  membrane  and  factor Va. In  this  sense,  the effect of 
factor Va is to increase  considerably the effective or empirical 
binding  constant for factor  Xa for the  membrane  (Nesheim 
et al., 1979, 1981: Tracy et al., 1981; Krishnaswamy, 1990). 
The  term  containing  the phospholipid concentration  ([PL]) 
is required  only  because the formal  equilibria set  up by Krish- 
naswamy incorporate  the phospholipid concentration twice, 
while our approach  incorporates  it only  once. From a  purely 
thermodynamic viewpoint, either Krishnaswamy’s mechanis- 
tic development or our  empirical development can be used as 
long as  either one is used consistently. 
Values of the  empirical  prothrombinase assembly constant 
obtained by kinetic techniques in Mann’s laboratory (Nes- 
heim et al., 1979,1981; Tracy et al., 1981) or recently by more 
direct  methods  (Krishnaswamy, 1990) are  all  quite  consistent 
(-0.5-0.9 nM). Values obtained under similar conditions in 
other laboratories bracket the values obtained by Mann’s 
collaborators  (Lindhout et al. (1982): 0.05 nM; van de  Waart 
et al. (1984): 1 nM). Clearly, the bulk of the reported data 
favor  values of  0.5-0.9 nM for 25/75 PS/PC membranes.  For 
other  membrane compositions, this  parameter  has been ex- 
tracted from the rising edge of our phospholipid titration 
experiments (see “Results” and Table I of accompanying 
paper).  It is worth  noting  that  the values obtained from our 
titrations with human  proteins were entirely  consistent with 
the values reported  earlier from studies with  bovine proteins 
(Nesheim et al., 1979, 1981). 
It  should  be  noted  that  it  is  an  inherent  assumption  both 
in  our  empirical  treatment  and  in  the  mechanistic  treatment 
of Krishnaswamy (1990) that sufficient  free membrane  sur- 
face exists  that  the  binding of either  factor Va or factor  Xa 
does not interfere with the binding of the other protein, a 
situation referred to  as “surface crowding.” Past experience 
has shown that, even at  near  saturating  protein  concentra- 
tions, surface  crowding  probably has  little effect on  binding 
isotherms.3 
DETAILS OF THE  CALCULATIONS 
The  algorithm used to  calculate  the equilibrium concentra- 
tions of the  various  protein species was an  iterative procedure 
based on  the following conventional empirical  ligand binding 
equation (e.g. see Lentz  and  Hermans, 1989), 
L + s e L.S  
ulfLl = nIKd - u/Kd, 
where S represents a binding  site  on a  macromolecular  com- 
plex; ( L ]  = molar concentration of unbound ligand; [L],,, = 
total  concentration of ligand B = number of ligands bound 
per  macromolecular complex (usually per vesicle); n = number 
of binding sites per macromolecular complex (usually per 
vesicle). 
* G. A. Cutsforth, S. Krishnaswami, K. G. Mann, and B. R. Lentz, 
manuscript in preparation. G. A. Cutsforth, unpublished observations. 
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Next, substitute for v in terms of the fraction of ligand 
bound, fbound, 
fhound = ([Lltot - [LI)/[LI)tot 
Y = fhound [L]m 2N/[PL] 
0%. A21 
where [PL] = concentration of phospholipid available for 
binding, with 2N lipids per vesicle. 2N/n = stoichiometry of 
binding (moles of phospholipid/mole of protein); so that  the 
concentration of sites = [SI = [PL] *r2/2N. Substituting  Equa- 
tion A2 into A1 and using the  definition of a binding  site  as 
2N/n lipids, one  obtains  after rearranging: 
fbound*[L]tot - ([L]m + (n/2N/[PL] + K d f b o u n d  
(Es. A3) 
+ (n/2N)[PL] = 0 
Solving this  quadratic  equation gives the result: 
{bound = [([LItot (n/2N)[PL] + Kd) +- (([LII~I + (n/2N)[PL] 
(Es. A4) 
The negative root was taken for the solution to  this  quad- 
ratic since the  solution  resulting from the positive root did 
not give physically  meaningful  values  for the  fraction of ligand 
bound. In most cases, the macromolecular receptor was a 
membrane, but in some cases the macromolecular receptor 
was another  protein (e.g. factor Val. 
The only  difficulty  with this  calculation was that  all of the 
binding equilibria were linked; i.e. one ligand bound to  the 
membrane surface  reduced the surface  available to  bind  an- 
other ligand. In addition, ligand involved in one binding 
reaction was no longer  available  for binding  to  another ecep- 
tor (e.g. factor  Xa  binding  to  factor Va is not available to  bind 
to a membrane). For this  reason,  the  fraction of each  ligand 
bound had to be obtained by an iterative procedure. Each 
iteration  step  treated successively the following equilibria. 
Va + (2N/n)PL & Va.PL(,N/,, 
+ K J 2  - ~~~l~,t~n/~~/~~~l~'~21/2[Llt,t 
Xa + Va.PL(2Nln) * Xa.Va.PL(2N/,, 
Xa + Va Xa.Va (Es. A5) 
Xa + (2N/n)PL & Xa.PL,2N/n, 
I1 + (2N/n)PL 11. PL,,,") 
During  the  first  iteration,  the ligand  available  for binding 
was assumed  to  be  the  total ligand concentration, [L],,,, and 
the concentration of phospholipid membrane available for 
binding was assumed  to be the  total phospholipid concentra- 
tion. After the equilibrium concentration of each protein 
species (bound or free)  had been calculated, using Equation 
A4, the  remaining  concentration of phospholipid not  bound 
to  any  protein  plus  the  concentration of phospholipid  bound 
to a particular  protein was taken  as  the phospholipid  available 
for binding  to  that  protein  in  the  next  iteration.  Similarly,  in 
subsequent  iterations,  the pool of ligand  available  for binding 
to a particular  site was assumed  to be equal to  the  sum of the 
concentrations of the free  ligand and  the ligand bound  to  that 
site, as calculated in the previous iteration. In analogous 
fashion,  the  concentration of any  other macromolecular bind- 
ing  site available at  each  step was assumed  to  be  the  sum of 
the concentration of free sites plus sites occupied by the 
particular ligand under  consideration.  The convergence cri- 
terion was taken  to be a change  in  fraction bound of less than 
0.0001 between iterations.  The  algorithm  treated  the equilib- 
ria in the  order of tightest  binding species first  and weakest, 
last; however, reversing this  order of calculation did  not  alter 
the results. The details of the iteration procedure are de- 
scribed by the following pseudo code. 
The  initial  conditions  for  the  first  iteration  are  as follows. 
[VaPLI,, [XaVa],, [XaVaPL],, [XaPL],, [IIPL], = o 
(Es. A6) 
[Val, = [Val,; [PL], = [PLln; [Xa], = [Xa],; [II], = [ I I ] ~  
Step I-Calculate the  concentration of factor Va bound to 
the phospholipid (PL)  surface using the following parameters, 
[Ligand] = [Val, + [VaPL], (Es. A7) 
[Macromolecule] = [PL], + N1*[VaPLl1 
where Nl and Kd = stoichiometry  and dissociation constant, 
respectively,  for factor Va binding  to phospholipid  surface. 
Calculate [VaPL], using Equation A4. Update  the following 
concentrations. 
[Val, = [ligand] - [VaPL], 
[PL], = [macromolecule] - N,*[VaPL], 
(Eq. A8) 
Step 2"Calculate  the  concentration of factor  Xa bound to 
factor Va on  the  PL surface  using the following parameters. 
[Ligand] = [Xa], + [XaVaPL], 
[Macromolecule] = [VaPL], + N,*[XaVaPL], 
(Es. A9) 
where N2 and Kd = stoichiometry  and dissociation constant, 
respectively, for factor Xa bound to factor Va on the PL 
surface. 
Calculate [XaVaPLI2 using Equation A4. Update  the fol- 
lowing concentrations. 
[VaPL], = [macromolecule] - [XaVaPL], (Eq. A1O) 
[Xa], = [ligand] - [XaVaPL], 
Step 3"Calculate  the  concentration of factor  Xa bound to 
factor Va in bulk aqueous solution  using  the following param- 
eters. 
[Ligand] = [Xa], + [XaVa], 
[Macromolecule] = [Val, + [XaVa], 
where N3 and Kd = stoichiometry  and dissociation constant, 
respectively,  for factor  Xa bound to  factor Va in bulk aqueous 
solution. 
Calculate  [XaVa],  using Equation A4. Update  the following 
concentrations. 
(Eq. A l l )  
[Val, = [macromolecule] - [XaVa], (Eq. A12) 
[Xa], = [ligand] - [XaVa], 
Step 4"Calculate  the  concentration of factor Xa bound to 
phospholipid  surface  using the following parameters. 
[Ligand] = [Xa], + [XaPL], 
[Macromolecule] = [PL], + N4*[XaPL], 
where N4 and Kd = stoichiometry  and dissociation constant, 
respectively, for factor  Xa bound to phospholipid  surface. 
Calculate [XaPL], using Equation A4. Update  the following 
concentrations. 
(Eq. A13) 
[Xa], = [ligand] - [XaPL], 
[PL], = [macromolecule] - N4*[XaPL]:! 
(Eq. A14) 
Step 5"Calculate the concentration of prothrombin (11) 
bound to phospholipid surface using the following parameters. 
(Eq. A15) [Ligand] = [HII + [IIPL], 
[Macromolecule] = [PL]2 + Nb*[IIPL], 
where Ns and Kd = stoichiometry  and dissociation constant, 
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respectively, for prothrombin  bound  to phospholipid  surface. 
Calculate  [IIPL],  using  Equation A4. Update  the following 
concentrations. 
[II], = [ligand] - [IIPL], 
[PL12 = [macromolecule] - N5*[IIPL], 
(Eq. A161 
Step 6”Reassign parameter values in  preparation for sec- 
ond  iteration: 
[Val, = [Val,; [PL], = [PL12; [VaPLI, 
= [VaPL],; [XaVaPL], = [XaVaPLI2; 
[Xa], = [Xa],; [XaVa], = [XaVa],; [XaPL], (Eq. A17) 
= [XaPLI2; [IIPL], = [IIPL]?; 
[I111 = [I112 
Step 7-Check convergence criterion. If convergence crite- 
rion satisfied, then end; else return to Step 1 to continue 
iteration. 
PROPERTIES OF CALCULATED  PROTHROMBINASE  LIPID 
TITRATIONS 
The sensitivity of calculated phospholipid titration curves 
to several key parameters  is  illustrated in Fig. 2 .  In  our model, 
as  has  been  pointed  out before (Rosing et al., 1980; Pusey  and 
Nelsestuen, 1983), the increase in initial rate of thrombin 
formation results from an increase in the concentration of 
factor Xa bound to factor Va on the membrane surface. 
According to  the  binding  constants  that we have used  in  our 
calculation,  the  tight  binding of factor Va to  the  membrane 
condenses  formation of the  prothrombinase complex at  low 
phospholipid concentration. I t  is not surprising, then, that 
this  parameter  strongly affected the  position of the rising part 
of the  phospholipid  titration curve as well as  the position and 
height of the peak (see Fig. 2 A ) .  Unreasonably large pro- 
thrombin  binding  constants also had some effect  on  this rising 
portion (Fig. 2 B ) ,  due presumably  to  competition  with  factor 
Va binding. Consistent  with  our  interpretation of phospho- 
lipid inhibition (see “Discussion”),  the only parameter having 
a  significant effect on  the position of the falling part of the 
lipid titration curve  was the dissociation constant for factor 
Xa  binding  to a membrane (see Fig. 2 C ) .  The kinetic con- 
stants  (mainly k,,,) for the assembled prothrombinase com- 
plex had  little effect on  the position of the rising or falling 
edges or of the  peak of titration curves but  did change the 
height of the  maximum  in  the curve (calculations  not  shown). 
The empirical  dissociation constant for the  binding of factor 
Xa  to  membrane-bound  factor Va had a complex effect (see 
Fig. ZO), affecting  both  the  position  and  shape of the rising 
and falling edges as well as  the  height of the  peak of the lipid 
titration curve. However, it had only a small effect on the 
position of the peak. Since kc,, also  influenced the peak  height 
of the  titration curve, this  parameter  and  the K d  of factor  Xa 
binding  to  Va.PL showed  some  degeneracy in  their effects on 
the calculations. For  this reason, the rising edge of normalized 
phospholipid titration curves (with the influence of kc,, re- 
moved) were used to  estimate  the effective Kd for prothrom- 
binase assembly. 
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